The impact of personalized medicine of Type 2 diabetes mellitus in the global health context

Personalized Medicine
Pierre Paul Michel ThomasElena Ambrosino

Abstract

Advances in the fields of genomic sciences have given rise to personalized medicine. This new paradigm draws upon a patient's genetic and metabolic makeup in order to tailor diagnostics and treatment. Personalized medicine holds remarkable promises to improve prevention and management of chronic diseases of global relevance, such as Type 2 diabetes mellitus (T2DM). This review article aims at summarizing the evidence from genome-based sciences on T2DM risk and management in different populations and in the Global Health context. Opinions from leading experts in the field were also included. Based on these findings, strengths and weaknesses of personalized approach to T2DM in a global context are delineated. Implications for future research and implementation on that subject are discussed.

References

May 4, 2004·Statistics in Medicine·Lisa M SullivanRalph B D'Agostino
Jan 18, 2006·Annual Review of Medicine·Michel EichelbaumWilliam E Evans
Jan 18, 2006·Nature Genetics·Struan F A GrantKari Stefansson
Feb 17, 2006·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Susan HaririMuin J Khoury
Dec 19, 2006·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Susan HaririMuin J Khoury
May 4, 2007·The Journal of Clinical Investigation·Yan ShuKathleen M Giacomini
Aug 19, 2007·Journal of Inherited Metabolic Disease·A A Saadallah, M S Rashed
Oct 24, 2007·Clinical Pharmacology and Therapeutics·D A Cortese
Oct 31, 2008·Diabetes·Muin J KhouryAnn Albright
Nov 21, 2008·The New England Journal of Medicine·James B MeigsL Adrienne Cupples
Aug 28, 2009·Lancet·Bongani M MayosiDebbie Bradshaw
Oct 9, 2009·Nature·Teri A ManolioPeter M Visscher
May 1, 2008·Journal of Diabetes Science and Technology·David C Klonoff
Apr 17, 2010·Nature Reviews. Genetics·Noah A RosenbergMichael Boehnke
Jul 9, 2010·Current Pharmacogenomics and Personalized Medicine·V OzdemirM Z Salleh
Aug 26, 2010·JAMA : the Journal of the American Medical Association·Ronald C W MaJuliana C N Chan
Nov 16, 2010·Current Opinion in Oncology·Robert E Hewitt
Dec 4, 2010·Clinical Chemistry·Noemi Malandrino, Robert J Smith
Dec 28, 2010·Nature Genetics·UNKNOWN GoDARTS and UKPDS Diabetes Pharmacogenetics Study GroupEwan R Pearson
Dec 30, 2010·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Wylie BurkeUNKNOWN Ickworth Group
Mar 23, 2011·Nature Medicine·Thomas J WangRobert E Gerszten
May 4, 2011·Annals of Internal Medicine·David M EddyMacdonald Morris
Dec 1, 2011·Genome Medicine·Chunmei Huang, Jose C Florez
Mar 20, 2012·Cell·Frances M Ashcroft, Patrik Rorsman
May 9, 2012·Current Pharmacogenomics and Personalized Medicine·Louise WarnichGalen E B Wright
Aug 14, 2012·Nature Genetics·Andrew P MorrisUNKNOWN DIAbetes Genetics Replication And Meta-analysis (DIAGRAM) Consortium
Oct 30, 2012·Cell·René Bernards
Jan 8, 2013·Frontiers of Medicine·Weiping Jia
May 31, 2013·Clinical Pharmacokinetics·N van LeeuwenL M 't Hart
May 1, 2012·Diabetes Management·Richard W Grant, Deborah J Wexler
Aug 21, 2013·World Journal of Diabetes·Omar Ali
Oct 5, 2013·The Journal of Clinical Investigation·Thomas J WangRobert E Gerszten
Dec 20, 2013·Clinical and Translational Medicine·Ruslan DorfmanRenee Lyons
Feb 6, 2014·Rambam Maimonides Medical Journal·Harry S GlauberEddy Karnieli

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Methods Mentioned

BETA
genotyping
pharmacotherapy

Software Mentioned

Google Scholar

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved